PET/MRI is getting a lot of attention because of its potential to diagnose disease, but experts at a radiology meeting in Vienna advised practitioners to proceed with caution. "Novel imaging technology cannot enter routine clinical practice before diagnostic accuracy, influence on therapeutic management and economic factors have been carefully considered and evidenced by clinical studies," said Dr. Heinz-Peter Schlemmer, head of the radiology department at the German Cancer Research Center. However, despite drawbacks with PET/MRI, such as cost and technical challenges, Schlemmer and colleagues are optimistic that the modality, through research, will eventually prove its worth for cancer patients.

Related Summaries